AIP
CSBR icon

Ameritas Investment Partners’s Champions Oncology CSBR Stock Holding History

Ameritas Investment Partners’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-637
Closed -$7K – 3093
2021
Q1 		$7K Hold
637
– – ﹤0.01% 2944
2020
Q4 		$7K Hold
637
– – ﹤0.01% 2905
2020
Q3 		$6K Hold
637
– – ﹤0.01% 2914
2020
Q2 		$6K Buy
+637
New +$5.43K ﹤0.01% 2914

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Ameritas Investment Partners's CSBR Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Champions Oncology (CSBR) in Q2 2021, closing a stake of 637 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in CSBR in Q2 2020 and held it in 4 quarters. The position peaked at $7K in Q1 2021. 38 funds tracked by Wall St. Rank hold CSBR as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Champions Oncology position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 637 Champions Oncology shares in Q2 2021, an estimated $7K.
  • Ameritas Investment Partners first reported a position in Champions Oncology in Q2 2020 and held it in 4 quarters.
  • Ameritas Investment Partners's Champions Oncology position peaked at $7K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.